Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Gabriel Kwong
Georgia Institute of Technology, Department: Engineering (All Types)
Should you be removed from our database? Contact us at [email protected]. Read more below.
Glympse Bio
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Kwong invented a technology, entitled “Methods and Products for In Vivo Enzyme Profiling,” during your employment at MIT. He is the co-founder of Glympse, which obtained an exclusive option from MIT for this intellectual property. D.r Kwong owns (b)(4) of the company and serves as CTO. In addition, he receives more than (b)(4) per year from Glympse for consulting and related travel expenses.
The COI Committee reviewed Dr. Kwong's role on the research project in light of his financial interest in Glympse and the technology being studied. The Committee determined that Dr. Kwong has a manageable conflict of interest on this project because he holds equity in, and receives significant remuneration from Glympse, a company that has an exclusive option to license the technologies being studied. His financial interests could bias or appear to bias the design, conduct, or reporting of this research.
Noninvasive and predictive biomarkers of organ transplant rejection
Project Narrative Detecting early signs of organ transplant rejection is critical for the survival and health of the recipient, yet the biopsy remains the gold standard despite its invasiveness and limited predictive power. We propose to develop a new class of diagnostic agents that are administered and amplify disease signals for ultrasensitive and predictive monitoring of organ transplants.
Filed on January 03, 2018.
Tell us what you know about Gabriel Kwong's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Gabriel Kwong filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Gabriel Kwong | Georgia Institute of Technology | Conflict of Interest | Glympse Bio | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.